<p>Data are reported as mean ±SE.</p><p>Abbreviations used: MS, multiple sclerosis; m, male; f, female; BMI, body mass index; RR, relapsing remitting; CP, chronic progressive; EDSS, expanded disability status scale; NS, not significant.</p><p>Subject and disease characteristics and overview of secondary outcome measures in MS patients and healthy controls.</p
<p>SD = Standard Deviation; IQ = Interquartile Range; EDSS = Expanded Disability Status Scale; MSSS ...
Clinical outcome measures are critical to the assessment of disease status and progression for clini...
<p>Demographic and neurological assessment in Healthy Controls (HC) compared to patients with multip...
<p><sup>*</sup>P-values (crude) were calculated from analysis of variance (ANOVA), α = 0.05.</p><p><...
<p><i>Note</i>. Values are mean (standard deviation), unless otherwise noted. MS = multiple sclero...
<p>Data are expressed as mean (standard deviation) unless otherwise stated. <sup>a</sup>Data are exp...
<p>Values for age, MS disease duration, EDSS and EDSS change are medians with interquartile ranges i...
<p>M, male; F, female; yrs, years; R, relapsing; P, progressive; MSSS, Multiple.</p><p>Sclerosis Sev...
a<p>Age (in years) refers to age at sampling time point.</p>b<p>Disease duration (in years) refers t...
<p>Note: - = no data; BPF = brain parenchymal fraction; EDSS = expanded disability status scale; F =...
<p>Data are expressed as mean ± standard deviation. AMS: multiple sclerosis patients during disease ...
<p>Average ± SEM are shown; EDSS: Kurtzke Expanded Disability Status Scale; RR: relapsing-remitting ...
<p>Data are presented as mean ± SD, unless otherwise indicated. Abbreviations: RR-MS = relapsing-rem...
<p>Abbreviations: NCAND, Non-CNS-autoimmune neurological disorders; CAND, CNS-autoimmune neurologica...
<p>Notes: N—Number of examined samples; SD—standard deviation; EDSS: Expanded Disability Status Scal...
<p>SD = Standard Deviation; IQ = Interquartile Range; EDSS = Expanded Disability Status Scale; MSSS ...
Clinical outcome measures are critical to the assessment of disease status and progression for clini...
<p>Demographic and neurological assessment in Healthy Controls (HC) compared to patients with multip...
<p><sup>*</sup>P-values (crude) were calculated from analysis of variance (ANOVA), α = 0.05.</p><p><...
<p><i>Note</i>. Values are mean (standard deviation), unless otherwise noted. MS = multiple sclero...
<p>Data are expressed as mean (standard deviation) unless otherwise stated. <sup>a</sup>Data are exp...
<p>Values for age, MS disease duration, EDSS and EDSS change are medians with interquartile ranges i...
<p>M, male; F, female; yrs, years; R, relapsing; P, progressive; MSSS, Multiple.</p><p>Sclerosis Sev...
a<p>Age (in years) refers to age at sampling time point.</p>b<p>Disease duration (in years) refers t...
<p>Note: - = no data; BPF = brain parenchymal fraction; EDSS = expanded disability status scale; F =...
<p>Data are expressed as mean ± standard deviation. AMS: multiple sclerosis patients during disease ...
<p>Average ± SEM are shown; EDSS: Kurtzke Expanded Disability Status Scale; RR: relapsing-remitting ...
<p>Data are presented as mean ± SD, unless otherwise indicated. Abbreviations: RR-MS = relapsing-rem...
<p>Abbreviations: NCAND, Non-CNS-autoimmune neurological disorders; CAND, CNS-autoimmune neurologica...
<p>Notes: N—Number of examined samples; SD—standard deviation; EDSS: Expanded Disability Status Scal...
<p>SD = Standard Deviation; IQ = Interquartile Range; EDSS = Expanded Disability Status Scale; MSSS ...
Clinical outcome measures are critical to the assessment of disease status and progression for clini...
<p>Demographic and neurological assessment in Healthy Controls (HC) compared to patients with multip...